Myocardial Infarction

Category

Duke Clinical Research Institute Collaborates with BI & Eli Lilly to Lead EMPACT-MI Pragmatic Clinical Trial

Duke Clinical Research Institute (DCRI) inked a clinical trials collaborative deal with the world’s largest privately held drug company—Boehringer Ingelheim—and publicly traded Eli Lilly (NYSE:LLY) to launch the EMPACT-MI (EMPAgliflozin for the prevention of Chronic...

Pin It on Pinterest